Column Group IV GP, LP
SEC Form 4 insider trading activity
Column Group IV GP, LP has filed 2 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 8, 2026.
On the most recent filing, Column Group IV GP, LP is listed as 10% Owner at Eikon Therapeutics, Inc. Inside the rolling window, Column Group IV GP, LP reported 2 open-market purchases totaling $39.2M in EIKN and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,117,760 EIKN shares on Feb 6, 2026, worth $38.1M.
Companies traded
Other insiders at EIKN
Insider Buying
$39.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Column Group IV GP, LP made?
Column Group IV GP, LP has filed 2 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.
Which companies does Column Group IV GP, LP trade?
Column Group IV GP, LP has filed SEC Form 4 disclosures for 1 company, including EIKN.
When was Column Group IV GP, LP's most recent SEC Form 4 filing?
Column Group IV GP, LP's most recent SEC Form 4 filing on Tracefour is dated Sep 8, 2026.
What is Column Group IV GP, LP's total buy and sell value in the current window?
Inside the rolling retention window, Column Group IV GP, LP bought $39.2M and sold $0 based on SEC Form 4 filings.
What was Column Group IV GP, LP's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,117,760 EIKN shares on 2026-02-06, worth $38.1M, per SEC Form 4 filings.